Header cover image

Healthcare Sector

Results

2302

0 new

All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.

2302 companies

Embecta

Market Cap: US$658.1m

A medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.

EMBC

US$10.55

7D

-14.6%

1Y

-17.2%

IRADIMED

Market Cap: US$649.6m

Develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally.

IRMD

US$52.55

7D

-1.4%

1Y

21.8%

Replimune Group

Market Cap: US$649.1m

A clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer.

REPL

US$8.43

7D

-0.4%

1Y

68.3%

Simulations Plus

Market Cap: US$648.2m

Develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide.

SLP

US$31.81

7D

0.3%

1Y

-34.5%

Beta Bionics

Market Cap: US$648.2m

A commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes.

BBNX

US$14.95

7D

-3.9%

1Y

n/a

Vir Biotechnology

Market Cap: US$644.2m

A clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United States and internationally.

VIR

US$4.76

7D

5.5%

1Y

-52.9%

Trevi Therapeutics

Market Cap: US$640.0m

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough.

TRVI

US$6.16

7D

-4.8%

1Y

140.6%

Day One Biopharmaceuticals

Market Cap: US$638.6m

A commercial-stage company, focused on advancing class medicines for childhood and adult diseases with equal intensity in the United States.

DAWN

US$6.31

7D

0.3%

1Y

-54.1%

RxSight

Market Cap: US$637.2m

A commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States.

RXST

US$16.01

7D

-3.7%

1Y

-73.7%

Anavex Life Sciences

Market Cap: US$629.2m

A clinical stage biopharmaceutical company, engages in the development of therapeutics for the treatment of central nervous system diseases in the United States.

AVXL

US$7.58

7D

-2.6%

1Y

94.9%

Butterfly Network

Market Cap: US$625.6m

Develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally.

BFLY

US$2.63

7D

21.8%

1Y

163.0%

CeriBell

Market Cap: US$624.6m

Operates as a medical technology company focuses on transforming the diagnosis and management of patients with serious neurological conditions in the United States.

CBLL

US$17.19

7D

-2.1%

1Y

n/a

Evolus

Market Cap: US$624.1m

A performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.

EOLS

US$9.81

7D

-1.5%

1Y

-22.3%

Fulgent Genetics

Market Cap: US$618.3m

Provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally.

FLGT

US$20.19

7D

-4.9%

1Y

-6.6%

Mesa Laboratories

Market Cap: US$615.1m

Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.

MLAB

US$103.07

7D

-7.9%

1Y

-11.8%

Immatics

Market Cap: US$599.2m

A clinical-stage biopharmaceutical company, focuses on the research and development of potential T cell redirecting immunotherapies for the treatment of cancer in the United States.

IMTX

US$5.14

7D

0.4%

1Y

-55.5%

Regulus Therapeutics

Market Cap: US$598.1m

A clinical-stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States.

RGLS

US$7.93

7D

0.1%

1Y

272.3%

Iovance Biotherapeutics

Market Cap: US$594.4m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

IOVA

US$1.73

7D

-9.4%

1Y

-82.2%

Avanos Medical

Market Cap: US$591.9m

A medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America.

AVNS

US$12.43

7D

-2.1%

1Y

-35.8%

Keros Therapeutics

Market Cap: US$591.8m

A clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States.

KROS

US$14.35

7D

1.5%

1Y

-70.6%

Tian'an Technology Group

Market Cap: US$591.7m

Through its subsidiaries, engages in the research, development, and production of graphene products for the health therapy industry in China.

TANA.F

US$13.50

7D

3.8%

1Y

n/a

AnaptysBio

Market Cap: US$591.4m

A clinical-stage biotechnology company, focuses in delivering immunology therapeutics.

ANAB

US$20.90

7D

0.5%

1Y

-10.9%

AbCellera Biologics

Market Cap: US$591.0m

Engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.

ABCL

US$2.04

7D

2.5%

1Y

-50.0%

Integral Diagnostics

Market Cap: AU$904.5m

A healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand.

IDX

AU$2.43

7D

-1.2%

1Y

1.7%

NeuroPace

Market Cap: US$579.9m

Operates as a medical device company in the United States.

NPCE

US$12.66

7D

-29.6%

1Y

78.6%

Dianthus Therapeutics

Market Cap: US$576.6m

A clinical-stage biotechnology company, develops complement therapeutics for patients with severe autoimmune and inflammatory diseases.

DNTH

US$17.68

7D

-5.7%

1Y

-20.2%

PolyNovo

Market Cap: AU$891.2m

Designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally.

PNV

AU$1.29

7D

-5.5%

1Y

-40.0%

Advanced Medical Solutions Group

Market Cap: UK£424.1m

Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally.

AMS

UK£1.98

7D

0.3%

1Y

-5.8%

Delcath Systems

Market Cap: US$571.5m

An interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe.

DCTH

US$16.19

7D

-6.1%

1Y

126.4%

KalVista Pharmaceuticals

Market Cap: US$570.2m

A clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of drug therapies inhibitors for diseases with unmet needs.

KALV

US$11.22

7D

-8.3%

1Y

1.3%

Elite Pharmaceuticals

Market Cap: US$568.5m

A specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals.

ELTP

US$0.54

7D

7.6%

1Y

192.3%

Maravai LifeSciences Holdings

Market Cap: US$567.9m

A life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

MRVI

US$2.21

7D

-1.8%

1Y

-75.3%

Sionna Therapeutics

Market Cap: US$560.9m

A clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).

SION

US$13.08

7D

-6.6%

1Y

n/a

Taysha Gene Therapies

Market Cap: US$559.2m

A clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system.

TSHA

US$2.44

7D

-15.6%

1Y

-23.0%

Bicycle Therapeutics

Market Cap: US$556.1m

A clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom.

BCYC

US$8.20

7D

1.9%

1Y

-62.5%

Cogent Biosciences

Market Cap: US$556.0m

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

COGT

US$4.88

7D

-2.0%

1Y

-36.7%

Page 11 of 64